Physical training
OtherPhysical training during 24 weeks
NCT Number: NCT01116570
It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated to physiological and functional positive effects without alteration in quality of life. The review papers from Van der Kooi et al. (2005), Cup et al. (2007) and Féasson et al. (2010) suggest that the combination of endurance and strength training is even more relevant. Only a few controlled and randomized studies have been conducted on this topic. The impact of such training programs on the skeletal muscle regenerative capacities has not been yet addressed. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not regular exercise practice can be maintained in patient's daily life. Also, only a few experiments have reported an integrative view of the potential benefits of such programs on functional, biological and quality of life.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
CHU de Grenoble, Grenoble, France
Our research project aims at establishing a program of physical training that will fulfill the two following conditions: (i) being compatible with the daily professional, social and family activity of the patients so it can be integrated in their life habits and (ii) being intensive enough to induce functional benefits. This experimental work will be based on multi-factorial evaluations, i.e. biological, physiological, functional, and quality of life questionnaires. This work will be based on a collaboration between the Universities of Saint Etienne (L. Féasson), Grenoble (B Wuyam) and Örebro (F Kadi) within the Rhône-Alpes Reference Centre for Rare Neuromuscular Diseases (JC Antoine).
It is accepted that exercise therapy can be recommended for patients with myopathies but long-term training load still has to be determined for each pathology. In the specific context of facioscapulohumeral dystrophy, we aim at associating the scientific evaluation of physical activity benefits and a therapeutic education of patients in order to contribute to recommendations for physicians and physiotherapists. The purpose of this study is to combine an integrated approach with a better understanding of biological process implicated in this physiological treatment strategy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Physical training during 24 weeks
No intervention
Time frame: Week 24
VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle
Time frame: Day 0, Week 6, Week 12, Week 18 and Week 24
"short form 36 health survey questionnaire" SF36
Time frame: Day 0 and Week 24
biopsy of the vastus lateralis muscle
Time frame: Week 6, Week 12 and Week 18
VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle
Time frame: Day 0, Week 6, Week 12, Week 18 and Week 24
Fatigue severity scale (FSS)
Time frame: Inclusion
In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images.
Centre Hospitalier Universitaire de Saint Etienne
Other
Exercise and Myopathies. Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients: Functional, Tissue and Quality of Life Benefits.
Acronym: FSHD1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01689480
Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Grenoble, France
View Trial DetailsNCT05747924
Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral
Los Angeles, California, United States
View Trial DetailsNCT04154098
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Konstanz, Basen-Wuerttemberg, Germany
View Trial DetailsNCT00004685
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes
View Trial Details